Citation Impact
Citing Papers
Phase 1 and Pharmacokinetic Study of Lexatumumab in Patients with Advanced Cancers
2007
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
2012
Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma
2016
High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
2015
mTOR in aging, metabolism, and cancer
2013
Ferroptosis as a p53-mediated activity during tumour suppression
2015 StandoutNature
Hepatocellular carcinoma
2016 Standout
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Combination regimen with statins and NSAIDs: A promising strategy for cancer chemoprevention
2008
Rapamycin: One Drug, Many Effects
2014 Standout
Effect of metformin on cardiovascular events and mortality: a meta‐analysis of randomized clinical trials
2010
Proton pump inhibitors: an update of their clinical use and pharmacokinetics
2008
CRISPR–Cas9 genome engineering of primary CD4+ T cells for the interrogation of HIV–host factor interactions
2018 StandoutNobel
The Human Transcription Factors
2018 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis
2012
Serine, glycine and one-carbon units: cancer metabolism in full circle
2013
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
2011
Targeting apoptosis in cancer therapy
2020 Standout
Metabolic Regulation by p53 Family Members
2013
Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori
2010
Reactive oxygen species in cancer
2010 Standout
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
Cisplatin: The first metal based anticancer drug
2019 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors
2009
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer
2010
ROS signalling in the biology of cancer
2017 Standout
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
2018 StandoutNobel
Metformin Enhances Cisplatin Cytotoxicity by Suppressing Signal Transducer and Activator of Transcription–3 Activity Independently of the Liver Kinase B1–AMP-Activated Protein Kinase Pathway
2013
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first‐line treatment of metastatic colorectal cancer
2013
Fundamentals of cancer metabolism
2016 Standout
A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies
2010
Citrus flavonoid naringenin reduces mammary tumor cell viability, adipose mass, and adipose inflammation in obese ovariectomized mice
2017
Phase 2, multicenter, open‐label study of tigatuzumab (CS‐1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in chemotherapy‐naive patients with unresectable or metastatic pancreatic cancer
2013
The Therapeutic Potential of Naringenin: A Review of Clinical Trials
2019 Standout
Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice
2011 StandoutNobel
Works of Mathilde Jalving being referenced
Review article: the potential of combinational regimen with non‐steroidal anti‐inflammatory drugs in the chemoprevention of colorectal cancer
2005
Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: Potential targets for apoptosis induction
2005
Independent Induction of Caspase‐8 and cFLIP Expression during Colorectal Carcinogenesis in Sporadic and HNPCC Adenomas and Carcinomas
2007
Metformin: Taking away the candy for cancer?
2010
Increased risk of fundic gland polyps during long‐term proton pump inhibitor therapy
2006
Dysplasia in Fundic Gland Polyps is Associated with Nuclear β-Catenin Expression and Relatively High Cell Turnover Rates
2003